Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted?

BACKGROUND: Malignant glioma is an aggressive tumour commonly associated with a dismal outcome despite optimal surgical and radio-chemotherapy. Since 2005 temozolomide has been established as first-line chemotherapy. We investigate the role of in vivo glioma models in predicting clinical efficacy. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirst, T C, Vesterinen, H M, Sena, E S, Egan, K J, Macleod, M R, Whittle, I R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553514/
https://www.ncbi.nlm.nih.gov/pubmed/23321511
http://dx.doi.org/10.1038/bjc.2012.504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553514/
https://www.ncbi.nlm.nih.gov/pubmed/23321511
http://dx.doi.org/10.1038/bjc.2012.504

Ejemplares similares